Launch of a compliance services business for pharmaceutical manufacturers
First written in FY2023-Q2. 3 of 5 entries say "Advanced", first in FY2023-Q3. Latest entry: FY2026-H1.
No other company in this theme has enough history to compare yet.
- FY2026-H1AdvancedAnnual report
「The compliance services business, which verifies whether pharmaceutical manufacturers' materials and other content comply with various regulations, among other businesses, is expanding.」
The compliance services business that verifies the regulatory compliance of pharmaceutical manufacturers' materials and other content is expanding. - FY2025-H1AdvancedAnnual report
「In the publishing-related business, in addition to our existing materials production business, the convention and compliance services businesses, among others, are expanding.」
We state that new businesses, including the compliance services business for pharmaceutical manufacturers, are expanding together with the existing materials production business. - FY2024-Q3RestatedAnnual report
「We will also expand the convention business, which is expected to generate stable earnings, and provide high-quality services that comply with various regulations by combining the newly launched compliance services business with our existing materials production business.」
We continue to provide services by combining the newly launched compliance services business with our existing materials production business. - FY2023-Q3AdvancedAnnual report
「In the publishing-related business, the operating structure for the newly launched compliance business, in addition to our existing lecture and streaming businesses, is now in place, and we are focusing on business expansion.」
We have established the operating structure for the compliance services business that verifies whether pharmaceutical manufacturers' materials and other content comply with regulations, and are focusing on its expansion. - FY2023-Q2First statedAnnual report
「We have newly launched a compliance services business that verifies whether pharmaceutical manufacturers' materials and other content comply with various regulations, and are focusing on its expansion.」
We launched a new services business that verifies the compliance of pharmaceutical manufacturers' materials and other content with various regulations.